Bill Snyder

brain illustration

New approach may halt glioblastoma’s ability to grow

Vanderbilt University researchers have discovered a “backdoor” approach to blocking an enzyme that fuels the growth of glioblastoma, the most common and most fatal form of brain cancer.

Awards honor dedicated efforts of research staff

Krassimira Garbett, Ph.D., Patricia “Cookie” Minton, R.N., and Kent Shaddox are the recipients of the 2013 Research Staff Awards at Vanderbilt University Medical Center.

Pioneers of Discovery: Investigator seeks to debug cancer’s ‘bad software’

Beyond genetics — that’s the call Oliver McDonald, M.D., Ph.D., heard during the year between college and medical school he spent in a lab at St. Jude Children’s Research Hospital in Memphis.

Ancient chemical bond may aid cancer therapy: study

A chemical bond discovered by Vanderbilt University scientists that is essential for animal life and which hastened the “dawn of the animal kingdom” could lead to new therapies for cancer and other diseases.

VUMC positioned to meet challenges ahead: Balser

Jeff Balser, vice chancellor for health affairs and dean of the School of Medicine, announced Wednesday that workforce reduction efforts announced in September at Vanderbilt University Medical Center are completed.

Biodegradable scaffold may spur wound healing

Biomedical and chemical engineers at Vanderbilt University, working with a pathologist, have constructed a sponge-like, biodegradable tissue “scaffold” that releases an enzyme-blocking molecule to indirectly activate endogenous pathways and enhance tissue regeneration and wound healing.

1 92 93 94 95 96 109